Cargando…
Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development
Introduction: Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has had a disastrous effect worldwide during the previous three years due to widespread infections with SARS-CoV-2 and its emerging variations. More than 674 million confirmed cases and over 6.7 million deaths have been attribu...
Autores principales: | Islam, Md. Aminul, Shahi, Shatila, Marzan, Abdullah Al, Amin, Mohammad Ruhul, Hasan, Mohammad Nayeem, Hoque, M. Nazmul, Ghosh, Ajit, Barua, Abanti, Khan, Abbas, Dhama, Kuldeep, Chakraborty, Chiranjib, Bhattacharya, Prosun, Wei, Dong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941545/ https://www.ncbi.nlm.nih.gov/pubmed/36825152 http://dx.doi.org/10.3389/fphar.2023.1090717 |
Ejemplares similares
-
Some common deleterious mutations are shared in SARS-CoV-2 genomes from deceased COVID-19 patients across continents
por: Islam, Md. Aminul, et al.
Publicado: (2023) -
Recently emerged omicron subvariant BF.7 and its R346T mutation in the RBD region reveal increased transmissibility and higher resistance to neutralization antibodies: need to understand more under the current scenario of rising cases in China and fears of driving a new wave of the COVID-19 pandemic
por: Chakraborty, Chiranjib, et al.
Publicado: (2023) -
The D614G mutation helps to increase the transmissibility and reduce the virulence of SARS-CoV-2 variants through natural selection
por: Chakraborty, Chiranjib, et al.
Publicado: (2023) -
XBB.1.5: A new threatening SARS-CoV-2 Omicron subvariant
por: Islam, Md. Aminul, et al.
Publicado: (2023) -
The SARS-CoV-2 Omicron recombinant subvariants XBB, XBB.1, and XBB.1.5 are expanding rapidly with unique mutations, antibody evasion, and immune escape properties – an alarming global threat of a surge in COVID-19 cases again?
por: Chakraborty, Chiranjib, et al.
Publicado: (2023)